Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KIN

Kindred Biosciences

$10.70

-0.31 (-2.82%)

09:17
01/18/19
01/18
09:17
01/18/19
09:17
Syndicate
Kindred Biosciences 4.2M share Spot Secondary priced at $9.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

Over a month ago
KIN

Kindred Biosciences

$10.67

-0.34 (-3.09%)

16:02
01/17/19
01/17
16:02
01/17/19
16:02
Syndicate
Kindred Biosciences files to sell common stock, no amount given »

Barclays Capital Inc. and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIN

Kindred Biosciences

$11.56

0.25 (2.21%)

07:06
01/14/19
01/14
07:06
01/14/19
07:06
Hot Stocks
Kindred Biosciences announces 'positive' results from study of epoCat »

Kindred Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIN

Kindred Biosciences

$13.60

-0.06 (-0.44%)

07:30
12/03/18
12/03
07:30
12/03/18
07:30
Recommendations
Kindred Biosciences analyst commentary at Cantor Fitzgerald »

Kindred shares remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
KIN

Kindred Biosciences

$14.60

0.12 (0.83%)

07:15
11/08/18
11/08
07:15
11/08/18
07:15
Recommendations
Kindred Biosciences analyst commentary at H.C. Wainwright »

Kindred Biosciences price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIN

Kindred Biosciences

$14.56

0.08 (0.55%)

16:07
11/07/18
11/07
16:07
11/07/18
16:07
Earnings
Kindred Biosciences reports Q3 EPS (39c), consensus (37c) »

Reports Q3 revenue $0.6M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

KIN

Kindred Biosciences

$12.25

0.28 (2.34%)

07:43
10/31/18
10/31
07:43
10/31/18
07:43
Recommendations
Kindred Biosciences analyst commentary at Cantor Fitzgerald »

Kindred Biosciences price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

KIN

Kindred Biosciences

$12.25

0.28 (2.34%)

17:02
10/30/18
10/30
17:02
10/30/18
17:02
Hot Stocks
Kindred Biosciences reports 'positive' results from study of KIND-016 »

Kindred Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

KIN

Kindred Biosciences

$12.25

0.28 (2.34%)

16:55
10/30/18
10/30
16:55
10/30/18
16:55
Conference/Events
Kindred Biosciences to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

KIN

Kindred Biosciences

$12.25

0.28 (2.34%)

16:22
10/30/18
10/30
16:22
10/30/18
16:22
Conference/Events
Kindred Biosciences to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.